Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bio-tech + omega-3 is a combination immune nutrition intervention evaluated for its impact on postoperative outcomes in bladder cancer patients. The regimen consists of Bio-tech, a powder containing multivitamins and essential amino acids, and omega-3 plus, which provides omega-3 fatty acids. Administered perioperatively (one week before and two weeks after radical cystectomy), the combination is designed to modulate the immune response and reduce inflammatory complications. The intervention was studied in a Phase IV trial (NCT03147586) led by Mansoura University to assess its efficacy in decreasing 90-day morbidity following surgery. The components work synergistically to support protein synthesis and suppress pro-inflammatory cytokine production during the surgical recovery period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on multivitamins + amino acids + omega-3 fatty acids.